DIR Technologies Enters into Agreement with Pfizer
DIR Technologies’ to Deploy Inspection & Quality Control Solutions; Framework Established for Co-development Projects
Haifa, Israel – DIR Technologies, a provider of quality and process control solutions for pharmaceutical primary packaging, has announced a five-year agreement with Pfizer Inc. The agreement provides Pfizer with access to DIR Technologies’ first-to-industry inspection and quality control solutions, and sets the stage for joint projects pertaining to both product production and packaging line QA/QC processes.
Among the solutions involved in the agreement is DIR Technologies’ flagship Induction Integrity Verification System (I2VS). Introduced just over a year ago, the system is the first in the global pharmaceuticals market to perform in-line inspection on 100% of induction sealed bottles at the speed of the machine throughput. The I2VS is a workflow solution as well as an inspection device: the source of any potential faulty seals is indicated in real time, yielding a high degree of process understanding and the ability for operators to not only help fix potential faulty seals immediately, but oftentimes prevent them from occurring in the first place.
According to Roni Mansur, CEO of DIR Technologies: “Obviously, Pfizer is a well-established leader in pharmaceuticals manufacturing and part of our excitement in working with Pfizer is the company’s dedication to also being an industry pioneer in terms of technological advancement. Pfizer’s methodology of continuous improvement drives it to test and implement the best of cutting-edge solutions. It takes a true entrepreneurial spirit to lead the way and make a change, to implement technology that is different from the industry norm.”
Whereas sampling has been the standard methodology, the I2VS enables a new level of quality assurance and process control. After an extensive trial, Pfizer recently decided to adopt DIR’s inspection technology on select packaging lines.
DIR Technologies and Pfizer also will be working together on the development of a new inspection technology based on DIR’s advanced high-speed imaging capabilities. The new system is intended to perform 100 percent in-line inspection of tablets and capsules.
About DIR Technologies
DIR Technologies is the developer and provider of first-in-industry thermography-based inspection solutions for pharmaceutical primary packaging quality assurance and process control. DIR solutions offer a quantum leap from commonly used methods of sampling by providing 100% in-line, non-intrusive inspection that does not result in production slowdown. DIR Technologies is leading the way in the use of thermal imaging in the pharmaceutical industry for PAT applications and has filed several patents on the subject.
The company was established in 2009 and is jointly owned by major Israeli defense companies Rafael Advanced Defense Systems, LTD (www.rafael.co.il) and Elbit Systems (www.elbitsystems.com), and Israeli-American fund SCP Vitalife (www.scpvitalife.com). DIR Technologies is a spin-off of SCD – SemiConductor Devices (www.scd.co.il), one of the largest manufacturers of advanced Infrared sensors worldwide.